 Connection
Lauren Seeberger to Antiparkinson Agents
This is a "connection" page, showing publications Lauren Seeberger has written about Antiparkinson Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.176 |
|
|
|
-
Seeberger LC, Hauser RA. Carbidopa levodopa enteral suspension. Expert Opin Pharmacother. 2015; 16(18):2807-17.
Score: 0.477
-
Seeberger LC, Hauser RA. Levodopa/carbidopa/entacapone in Parkinson's disease. Expert Rev Neurother. 2009 Jul; 9(7):929-40.
Score: 0.306
-
Seeberger LC, Hauser RA. Optimizing bioavailability in the treatment of Parkinson's disease. Neuropharmacology. 2007 Dec; 53(7):791-800.
Score: 0.270
-
Wilson RE, Seeberger LC, Silver D, Griffith A, Conner JB, Salzman PM. Rasagiline: time to onset of antiparkinson effect is similar when used as a monotherapy or adjunct treatment. Neurologist. 2011 Nov; 17(6):318-24.
Score: 0.090
-
Frank MJ, Seeberger LC, O'reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science. 2004 Dec 10; 306(5703):1940-3.
Score: 0.014
-
Hauser RA, Friedlander J, Zesiewicz TA, Adler CH, Seeberger LC, O'Brien CF, Molho ES, Factor SA. A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia. Clin Neuropharmacol. 2000 Mar-Apr; 23(2):75-81.
Score: 0.010
-
Trosch RM, Friedman JH, Lannon MC, Pahwa R, Smith D, Seeberger LC, O'Brien CF, LeWitt PA, Koller WC. Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience. Mov Disord. 1998 May; 13(3):377-82.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|